Kaken Pharmaceutical Co., Ltd. (4521.T)

Home
4521.T
Financials

3893 (JPY) • At close November 5, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004
Revenue Numbers are in millions	72,044	72,984	76,034	74,979	89,234	94,167	98,432	101,991	109,218	93,895	88,949	87,047	87,994	86,433	85,026	82,927	79,944	76,414	75,525	74,923
Cost of Revenue Numbers are in millions	33,822	33,428	34,458	34,073	38,753	40,366	42,405	44,539	47,580	44,760	45,169	44,961	44,928	44,069	44,120	43,140	41,246	39,220	38,492	37,752
Gross Profit Numbers are in millions	38,222	39,556	41,576	40,906	50,481	53,801	56,027	57,452	61,638	49,135	43,780	42,086	43,066	42,364	40,906	39,787	38,698	37,194	37,033	37,171
Gross Profit Ratio Numbers are in millions	0.531	0.542	0.547	0.546	0.566	0.571	0.569	0.563	0.564	0.523	0.492	0.483	0.489	0.49	0.481	0.48	0.484	0.487	0.49	0.496
Reseach & Development Expenses Numbers are in millions	12,543	15,789	8,420	6,736	6,418	10,261	8,152	6,450	5,883	7,615	7,045	6,302	6,592	6,853	7,873	7,696	6,808	6,533	6,045	6,271
General & Administrative Expenses Numbers are in millions	31	0	0	0	0	0	0	0	0	0	0	1,670	2,033	1,898	1,835	2,705	2,783	1,811	1,946	1,920
Selling & Marketing Expenses Numbers are in millions	16,134	0	0	0	0	0	0	0	0	0	0	1,469	1,707	1,779	1,724	2,135	2,485	2,614	2,594	2,763
SG&A Numbers are in millions	16,165	15,476	15,833	16,155	17,320	18,724	20,174	20,020	20,304	20,589	20,591	3,139	3,740	3,677	3,559	4,840	5,268	4,425	4,540	4,683
Other Expenses Numbers are in millions	57	334	130	69	110	85	92	47	47	-426	-506	-445	-317	-407	-397	-243	-390	-352	-435	-424
Operating Expenses Numbers are in millions	28,708	31,553	24,508	23,115	23,966	29,205	28,527	26,741	26,486	28,502	27,905	27,469	23,977	24,138	25,364	25,282	24,813	24,762	24,340	24,863
Operating Income Numbers are in millions	9,514	7,998	17,064	17,788	26,512	24,592	27,496	30,707	35,146	20,631	15,872	14,611	19,089	18,226	15,542	14,505	13,885	12,432	12,693	12,308
Operating Income Ratio Numbers are in millions	0.132	0.11	0.224	0.237	0.297	0.261	0.279	0.301	0.322	0.22	0.178	0.168	0.217	0.211	0.183	0.175	0.174	0.163	0.168	0.164
Total Other Income Expenses Net Numbers are in millions	282	-1,183	-3,180	869	80	330	186	381	140	-2,022	-379	-439	-4,523	-4,681	-4,613	-5,151	-5,282	-4,649	-5,366	-6,227
Income Before Tax Numbers are in millions	9,796	6,817	13,885	18,657	26,592	24,922	27,686	31,092	35,292	18,611	15,496	14,178	14,566	13,545	10,929	9,354	8,603	7,783	7,327	6,081
Income Before Tax Ratio Numbers are in millions	0.136	0.093	0.183	0.249	0.298	0.265	0.281	0.305	0.323	0.198	0.174	0.163	0.166	0.157	0.129	0.113	0.108	0.102	0.097	0.081
Income Tax Expense Numbers are in millions	1,770	1,377	4,336	5,252	7,222	7,147	8,643	9,075	14,148	6,488	5,761	5,186	6,283	5,332	4,194	3,774	3,497	3,180	3,441	2,664
Net Income Numbers are in millions	8,025	5,440	9,549	13,405	19,370	17,775	19,043	22,017	21,143	12,122	9,735	8,991	8,282	8,213	6,734	5,579	5,106	4,602	3,886	3,417
Net Income Ratio Numbers are in millions	0.111	0.075	0.126	0.179	0.217	0.189	0.193	0.216	0.194	0.129	0.109	0.103	0.094	0.095	0.079	0.067	0.064	0.06	0.051	0.046
EPS Numbers are in millions	212.66	144.79	251.44	347.37	494.89	445.78	470.55	536.7	510.54	290.9	228.28	206.6	184.92	175.74	137.58	111.22	96.7	84.84	80.46	73.08
EPS Diluted Numbers are in millions	212.66	144.79	251.44	347.37	494.89	445.78	470.55	536.7	510.54	290.9	228.28	206.6	184.92	175.74	137.58	111.22	96.22	81.66	66.48	56.98
EBITDA Numbers are in millions	12,267	11,338	20,045	20,557	29,275	27,140	29,994	32,939	37,634	22,821	18,102	16,925	21,202	20,321	17,584	16,708	15,814	14,083	13,818	13,032
EBITDA Ratio Numbers are in millions	0.17	0.155	0.264	0.274	0.328	0.288	0.305	0.323	0.345	0.243	0.204	0.194	0.241	0.235	0.207	0.201	0.198	0.184	0.183	0.174

Kaken Pharmaceutical Co., Ltd.

TSE:4521.T Add to watchlist

TSE:4521.T